Literature DB >> 8423800

Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product.

A M Chan1, T P Fleming, E S McGovern, M Chedid, T Miki, S A Aaronson.   

Abstract

Using an expression cDNA cloning approach, we examined human tumor cell lines for novel oncogenes that might evade detection by conventional techniques. We isolated a transforming sequence that was highly efficient in transforming NIH 3T3 mouse fibroblasts. DNA sequence analysis identified the gene as the human homolog of a recently cloned alpha subunit of mouse GTP-binding protein G alpha 12. NIH 3T3 cells transfected with G alpha 12 cDNA grew in soft agar and were tumorigenic in nude mice. There were no apparent mutations in the cloned cDNA in comparison with a G alpha 12 cDNA clone isolated from a normal human epithelial cell library, implying that overexpression alone was sufficient to cause NIH 3T3 cell transformation. The observed altered growth properties mediated by G alpha 12 showed a certain degree of dependency on serum factors, and its mitogenic potential was also potently inhibited by suramin treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423800      PMCID: PMC358958          DOI: 10.1128/mcb.13.2.762-768.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  29 in total

1.  G proteins. The target sets the tempo.

Authors:  H R Bourne; L Stryer
Journal:  Nature       Date:  1992-08-13       Impact factor: 49.962

2.  Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells.

Authors:  M Wigler; S Silverstein; L S Lee; A Pellicer; Y c Cheng; R Axel
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

3.  GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.

Authors:  C A Landis; S B Masters; A Spada; A M Pace; H R Bourne; L Vallar
Journal:  Nature       Date:  1989-08-31       Impact factor: 49.962

4.  An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency.

Authors:  T Miki; T Matsui; M A Heidaran; S A Aaronson
Journal:  Gene       Date:  1989-11-15       Impact factor: 3.688

5.  Purification and characterization of a newly identified growth factor specific for epithelial cells.

Authors:  J S Rubin; H Osada; P W Finch; W G Taylor; S Rudikoff; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene.

Authors:  M R Stampfer; J C Bartley
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 7.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

8.  Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.

Authors:  C Betsholtz; A Johnsson; C H Heldin; B Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

9.  Chromosome changes in soft tissue sarcomas.

Authors:  R Becher; N Wake; Z Gibas; H Ochi; A A Sandberg
Journal:  J Natl Cancer Inst       Date:  1984-04       Impact factor: 13.506

10.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.

Authors:  P P Di Fiore; J H Pierce; T P Fleming; R Hazan; A Ullrich; C R King; J Schlessinger; S A Aaronson
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

View more
  49 in total

1.  Identification of 20 novel SNPs in the guanine nucleotide binding protein alpha 12 gene locus.

Authors:  Aritoshi Iida; Susumu Saito; Akihiro Sekine; Wataru Tabei; Yukie Kataoka; Yusuke Nakamura
Journal:  J Hum Genet       Date:  2004-06-18       Impact factor: 3.172

Review 2.  G protein-coupled receptors: novel targets for drug discovery in cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Nat Rev Drug Discov       Date:  2011-01       Impact factor: 84.694

3.  Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells.

Authors:  G R Post; L R Collins; E D Kennedy; S A Moskowitz; A M Aragay; D Goldstein; J H Brown
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

4.  Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers.

Authors:  Lutz Birnbaumer
Journal:  Biochim Biophys Acta       Date:  2006-12-15

Review 5.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

Review 6.  Regulation and physiological functions of G12/13-mediated signaling pathways.

Authors:  Nobuchika Suzuki; Nicole Hajicek; Tohru Kozasa
Journal:  Neurosignals       Date:  2009-02-12

Review 7.  Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13.

Authors:  Tohru Kozasa; Nicole Hajicek; Christina R Chow; Nobuchika Suzuki
Journal:  J Biochem       Date:  2011-08-26       Impact factor: 3.387

Review 8.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.

Authors:  T A Fields; P J Casey
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

9.  The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation.

Authors:  C Fromm; O A Coso; S Montaner; N Xu; J S Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

10.  Gα12 structural determinants of Hsp90 interaction are necessary for serum response element-mediated transcriptional activation.

Authors:  Ellyn R Montgomery; Brenda R S Temple; Kimberly A Peters; Caitlin E Tolbert; Brandon K Booker; Joseph W Martin; Tyler P Hamilton; Alicia C Tagliatela; William C Smolski; Stephen L Rogers; Alan M Jones; Thomas E Meigs
Journal:  Mol Pharmacol       Date:  2014-01-16       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.